Jasper Therapeutics, Inc. (JSPR)
0.6932
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 13:39
Jasper Therapeutics Shareholders Equity (Quarterly) : 1.413M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.413M |
| March 31, 2026 | 3.40M |
| December 31, 2025 | 4.151M |
| September 30, 2025 | 11.57M |
| June 30, 2025 | 23.50M |
| March 31, 2025 | 42.24M |
| December 31, 2024 | 61.67M |
| September 30, 2024 | 83.68M |
| June 30, 2024 | 100.31M |
| March 31, 2024 | 113.23M |
| December 31, 2023 | 78.44M |
| September 30, 2023 | 94.13M |
| June 30, 2023 | 110.20M |
| March 31, 2023 | 125.20M |
| Date | Value |
|---|---|
| December 31, 2022 | 35.99M |
| September 30, 2022 | 47.56M |
| June 30, 2022 | 58.78M |
| March 31, 2022 | 68.10M |
| December 31, 2021 | 69.52M |
| September 30, 2021 | 78.60M |
| June 30, 2021 | 86.29M |
| March 31, 2021 | 89.86M |
| December 31, 2020 | 8.71M |
| September 30, 2020 | 97.64M |
| June 30, 2020 | 97.84M |
| March 31, 2020 | 98.12M |
| December 31, 2019 | |
| September 30, 2019 | 0.024M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.80M |
| Total Liabilities (Quarterly) | 10.39M |
| Debt to Equity Ratio | 0.1911 |
| Current Ratio | 1.475 |
| Net Debt Paydown Yield | 3.92% |